Skip to main navigation Skip to search Skip to main content

Determining priority signs and symptoms for use as clinical outcomes assessments in trials including patients with malignant gliomas: Panel 1 Report

  • Terri S. Armstrong
  • , Allison M. Bishof
  • , Paul D. Brown
  • , Martin Klein
  • , MJB Taphoorn
  • , Christina Theodore-Oklota

Research output: Contribution to journalArticleAcademicpeer-review

31 Downloads (Pure)
Original languageEnglish
Pages (from-to)1-12
JournalNeuro-oncology
Volume18
DOIs
Publication statusPublished - Mar 2016

Keywords

  • clinical outcomes assessment
  • glioblastoma
  • glioma
  • outcomes
  • signs and symptoms

Cite this